Selected category: Biopharma & Drug Discovery

Brain tumors are the most common cause of mortality in childhood cancer patients, and treatment options are limited, especially for recurrent cases. Researchers at the University Hospital Düsseldorf are using automation to develop a more personalized approach to cancer medicine, performing rapid drug screening to identify novel therapeutic strategies to improve the chances of survival.

Scientists at Columbia University have created three flexible, fully automated workstations based on Freedom EVO® 200 platforms for the assay development work they are performing as part of the NIH Molecular Libraries Roadmap initiative.